1. COVID-19 Peripheral Neuropathy: A Report of Three Cases
- Author
-
Keith B. Diamond, Mitchell Ng, David R. Edelstein, Orry Erez, and Miriam D. Weisberg
- Subjects
medicine.medical_specialty ,peripheral neuropathy ,Coronavirus disease 2019 (COVID-19) ,Lateral femoral cutaneous nerve ,Ulnar neuropathy ,ulnar neuropathy ,lateral femoral cutaneous nerve ,medicine ,ain neuropathy ,anterior interosseous nerve neuropathy ,lfcn neuropathy ,Meralgia paresthetica ,business.industry ,meralgia paresthetica ,General Engineering ,medicine.disease ,Anterior interosseous nerve ,Peripheral ,Surgery ,Peripheral neuropathy ,Orthopedics ,Neurology ,covid-19 ,critical care polyneuropathy ,Epidemiology/Public Health ,business ,Polyneuropathy - Abstract
This study includes three patients with various peripheral neuropathies after contracting coronavirus disease 2019 (COVID-19) infection, treated both conservatively and surgically. While cases of neurological complications have been described, neuropathy associated with COVID-19 is under-reported in orthopaedic literature. These patients presented with ulnar neuropathy, critical care polyneuropathy (CCP) with anterior interosseous nerve (AIN) neuropathy, and lateral femoral cutaneous nerve (LFCN) neuropathy. COVID-19 infection may be associated with peripheral neuropathy in addition to various neurological sequelae. Orthopaedic surgeons should screen patients for recent infections and evaluate the severity of the illness to assess for risk of neurological sequelae of COVID-19 infection.
- Published
- 2021